COVID-19 Therapeutics

COVID-19 Therapeutics

Referral Info For Patients & Providers

Effective 12/1/2022, Total Infusion is no longer administering Bebtelovimab due to the rapid surge in resistant Omicron subvariants.
Read FDA Statement

Effective 1/26/2023, Total Infusion is no longer administering EVUSHELD due to resistant Omicron subvariants.
Read FDA Statement

Limited Access Available
Requires 3 Day Consecutive Treatment

Same Day Testing and Oral Antivirals Coming Soon!

ADDRESS:

Eastmont Town Center 6955 Foothill Blvd, Suite 67A, Oakland, CA, 94605

BUSINESS HOURS:

Monday – Friday:

8:30am-5:00pm